Slope of change in HbA(1c) from baseline with empagliflozin compared with sitagliptin or glimepiride in patients with type 2 diabetes

AIMS: To analyse the effect of baseline glycated haemoglobin (HbA(1c)) on the reduction in HbA(1c) with empagliflozin compared with sitagliptin or glimepiride in patients with type 2 diabetes. MATERIALS AND METHODS: Using regression analyses of individual patient data from two Phase III studies, we...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Endocrinol Diabetes Metab
Autors principals: DeFronzo, Ralph A., Ferrannini, Ele, Schernthaner, Guntram, Hantel, Stefan, Elsasser, Ulrich, Lee, Christopher, Hach, Thomas, Lund, Søren S.
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2018
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6354821/
https://ncbi.nlm.nih.gov/pubmed/30815552
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/edm2.16
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars